Deerland Probiotics & Enzymes

What Deerland Probiotics & Enzymes does

Deerland Probiotics & Enzymes, founded in 1990 and headquartered in Kennesaw, Georgia, is a B2B formulator and contract manufacturer of clinically validated enzyme and probiotic-based dietary supplement ingredients. The company supplies manufacturers of functional foods, beverages, dietary supplements, pharmaceuticals, and pet/animal nutrition, serving as an upstream ingredient provider rather than a finished-product brand. Following its 2021 acquisition by ADM (Archer Daniels Midland), Deerland operates as part of ADM's Human Nutrition division under the Microbiome Solutions unit.

Name

Deerland Probiotics & Enzymes

Legal name

Deerland Enzymes, Inc.

Website

https://deerland.com

Company type

Private

Founded year

1990

Operating status

Acquired

Headcount range

251–500 employees

Short description

Deerland Probiotics & Enzymes is a B2B supplier of clinically validated probiotic, prebiotic, postbiotic, enzyme, and bacteriophage ingredients serving functional food, dietary supplement, pharmaceutical, and pet nutrition manufacturers worldwide. Founded in 1990, it operates within ADM's Human Nutrition division following its 2021 acquisition.

Ownership category

akta.pro rank

Product category

Probiotic and Enzyme Ingredients

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Prebiotics & Dietary Fibers (Inulin, FOS/GOS, Resistant Starch, Beta-Glucan, Psyllium) (AFAJAKAF)

akta.pro secondary industries

Probiotics, Prebiotics & Postbiotics (Direct-Fed Microbials) (AFADALAE), Enzyme Premixes (Phytase, NSP Enzymes, Proteases) (AFADAGAF)

Keywords

• Probiotic ingredients
• Enzyme manufacturing
• Prebiotic supplements
• Dietary supplement ingredients
• Microbiome solutions

Headquarters

HQ city

Kennesaw

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. B2B Ingredients Sales: Deerland generates revenue by selling probiotic, prebiotic, postbiotic, and enzyme ingredients to manufacturers of functional foods, beverages, dietary supplements, pharmaceuticals, and pet/animal nutrition. The business model is B2B ingredient supply, with customers integrating Deerland's branded ingredients into their own finished products. As part of ADM, Deerland's revenue flows through ADM's broader human nutrition and ingredient sales channels.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Deerland Probiotics & Enzymes is a formulator and supplier of clinically validated probiotic, prebiotic, postbiotic, enzyme, and bacteriophage ingredients sold on a B2B basis to manufacturers of functional foods, beverages, dietary supplements, pharmaceuticals, and pet/animal nutrition products. The portfolio spans 12 branded product lines, including proprietary probiotic strains (BPL1, DE111, ES1, L. rhamnosus CNCM I-4036, L. gasseri CP2305), enzymes (Nattozimes, ProHydrolase, Serrazimes), prebiotic fibers (Fibersol), bacteriophage technology (PreforPro), and purpose-built blends (Active Lifestyle Blend, Mood & Stress Blend, AD Blend, Smooth Skin Blend, Male Virility Blend). As a subsidiary of ADM since 2021, Deerland's ingredients are integrated into finished products targeting digestive health, immune function, metabolic health, sports nutrition, women's health, and mental wellbeing.

Product overview

Deerland Probiotics & Enzymes, acquired by ADM in 2021, is a provider of probiotic and dietary supplements using probiotic, prebiotic, and enzyme technology with 12 branded product lines. The portfolio is organized into five core product categories: Prebiotics (including Fibersol and PreforPro), Probiotics (including BPL1, DE111, ES1, and Lactic Acid Bacteria/Spores strains), Postbiotics (with formulation flexibility for harsh processing), Bacteriophage Technology (PreforPro for microbiome modulation), and Enzymes (including ProHydrolase, Serrazimes, and Nattozimes). These ingredients are offered both as individual branded products and in purpose-built blended formulations such as Active Lifestyle Blend, Mood & Stress Blend, AD Blend, Smooth Skin Blend, and Male Virility Blend. The products target health applications including digestive health, immune function, metabolic health, active lifestyle/sports nutrition, women's health, beauty from within, healthy aging, and mental wellbeing.

Differentiator

Problem solved

Functional benefit

Products and services

• Probiotics Broad portfolio of clinically studied probiotic strains including BPL1, DE111, ES1, L. rhamnosus CNCM I-4036, Lactic Acid Bacteria, and Spore-based formulations targeting digestive health, immune function, metabolic health, and active lifestyle applications. Sold B2B to manufacturers integrating the strains into finished products.
• Prebiotics Prebiotic ingredients that support beneficial gut bacteria growth, including the Fibersol fiber and the bacteriophage-based PreforPro. Sold B2B to functional food, beverage, dietary supplement, and pet nutrition manufacturers.
• Postbiotics Postbiotic formulations offering formulation flexibility for applications with harsh processing conditions, including the BPL1 postbiotic. Sold B2B to functional food, beverage, and dietary supplement manufacturers requiring shelf-stable and processing-resilient microbiome ingredients.
• Bacteriophage Technology (Phages) Bacteriophage-based microbiome modulators, featuring PreforPro, that target unwanted bacteria to allow beneficial bacteria to flourish. Sold B2B to functional food, dietary supplement, and pet nutrition manufacturers.
• Enzymes Full range of enzyme solutions including ProHydrolase and Serrazimes for active lifestyle and sports nutrition applications, plus Nattozimes for metabolic health. Sold B2B to dietary supplement, functional food, and pet nutrition manufacturers.
• Active Lifestyle Blend Purpose-built clinically studied probiotic blend supporting sports nutrition, muscle support, and joint health. Sold B2B as a blended ingredient to dietary supplement and functional food manufacturers.
• Mood & Stress Blend Purpose-built probiotic blend for mental wellbeing supporting focus, mood, and stress. Sold B2B as a blended ingredient to dietary supplement manufacturers.
• AD Blend Clinically studied probiotic blend for beauty-from-within skin health applications. Sold B2B as a blended ingredient to dietary supplement and functional food manufacturers.
• Smooth Skin Blend Probiotic blend for skin health improvement, targeting beauty-from-within applications. Sold B2B as a blended ingredient to dietary supplement and functional food manufacturers.
• Male Virility Blend Purpose-built blend supporting men's health and healthy living. Sold B2B as a blended ingredient to dietary supplement manufacturers.

Quantifiable outcome

• 58 percent of global consumers are aware of the benefits that bacteria have in the digestive system and attribute its impact to a wide variety of wellness areas

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• ADM (Archer Daniels Midland)flagshipOthersADM acquired Deerland Probiotics & Enzymes in 2021. The acquisition significantly expanded ADM's human nutrition and microbiome solutions portfolio, adding 12 branded product lines and probiotic, prebiotic, and enzyme capabilities to ADM's existing offerings. Deerland now operates as a subsidiary/brand under ADM's Human Nutrition division's Microbiome Solutions unit. The relationship is one of parent company acquisition rather than a commercial partnership.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• BioGaia: BioGaia is a Swedish probiotics specialist offering clinically documented Lactobacillus and Bifidobacterium strains primarily for dietary supplements and infant formula. It overlaps directly with Deerland on clinically validated probiotic strains for supplement and functional food customers.
• Novonesis (formerly Chr. Hansen): Novonesis is a global leader in microbial and fermentation-based solutions, including a broad portfolio of clinically documented probiotic strains, enzymes, and bioprotective cultures for food, supplement, and pharma applications. It is the most direct competitor to Deerland across probiotics, enzymes, and postbiotics at enterprise scale.
• IFF Health & Biosciences (formerly DuPont Nutrition & Biosciences): IFF Health & Biosciences supplies probiotic strains (e.g., HOWARU), enzymes, and biotic ingredients to dietary supplement and functional food manufacturers globally. It competes head-to-head with Deerland in clinically validated probiotics for the same B2B customer base.
• Lesaffre (Gnosis by Lesaffre): Lesaffre, through its Gnosis business, supplies yeast-based probiotic and postbiotic ingredients (e.g., Saccharomyces boulardii, yeast fractions) with clinical evidence for supplements and functional food. It competes with Deerland's probiotic and postbiotic categories.
• AB Biotics (AB Enzymes): AB Biotics develops and commercializes proprietary probiotic strains for human health, with clinical evidence backing applications in digestive, metabolic, and women's health. It is a direct, specialized peer to Deerland's strain-specific probiotic business.
• Lallemand Health Solutions: Lallemand Health Solutions offers a broad range of probiotic yeast and bacterial strains, with strong clinical substantiation, targeting dietary supplements and functional foods. It directly overlaps Deerland's strain-specific, evidence-led positioning in human nutrition.
• Probi AB: Probi is a probiotic B2B ingredient supplier with clinically documented strains for digestive, immune, and metabolic health, serving supplement and food manufacturers globally. It is a like-for-like peer in the B2B probiotic ingredients space.

Emerging players

• Lonza Capsules & Health Ingredients: Lonza's Health Ingredients business is expanding into microbial and biotic ingredients alongside its core capsule and formulation offerings, targeting supplement and nutrition customers. It is an emerging player in probiotic and postbiotic ingredients, overlapping with part of Deerland's portfolio.

Broad incumbents

• Kemin Industries: Kemin Industries supplies specialty ingredients, including probiotics and enzymes, for human and animal nutrition through a global B2B sales footprint. It is a broader incumbent with overlapping biotic ingredient capabilities versus Deerland's more focused portfolio.
• Kerry Group: Kerry Group is a global taste and nutrition ingredients company with a sizable portfolio in probiotics, enzymes, and functional ingredients serving food, beverage, and supplement customers. It overlaps with Deerland as a broad incumbent in B2B functional nutrition rather than a probiotics specialist.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/adm
• Xx.com/DeerlandEnzymes
• Facebookfacebook.com/deerlandenzymes

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Deerland Probiotics & Enzymes